Kaposi s Sarcoma (KS) Completed Phase 2 Trials for Semaxanib (DB06436)

Also known as: Kaposi's sarcomas / Kaposi's sarcoma / Kaposi Sarcoma (KS) / Sarcoma, Kaposi / KaposiĀ“s Sarcoma / Kaposi Sarcoma / Kaposi' s Sarcoma / Multiple idiopathic hemorrhagic sarcoma / Multiple idiopathic haemorrhagic sarcoma / Kaposi's sarcoma, unspecified / Kaposi's sarcoma NOS / Multiple haemorrhagic sarcoma / Multiple hemorrhagic sarcoma

IndicationStatusPhase
DBCOND0035013 (Kaposi s Sarcoma (KS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00005931SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to TreatmentTreatment